Hormonal health & BHRT
Hormone therapy, including compounded bioidentical hormones, testosterone therapy and menopause care.
Emerging
- Editorial attention
- Emerging
- Tracked this week
- 2
- Sources this week
- 2
- Last activity
- 18 hrs ago
Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
Hormonal health & BHRT at a glance
- About this topic
- Hormone therapy, including compounded bioidentical hormones, testosterone therapy and menopause care.
- Current status
- No editor-reviewed status summary yet. The official records below update automatically.
- Last updated
- Primary sources
- Latest official record: Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society (opens the source in a new tab) (Maturitas, Sep 30, 2026)
What’s the latest on Hormonal health & BHRT?
0 totalNo briefings on this topic yet. Official records and trials below are updated continuously.
What do the official records show?
Primary sources and peer-reviewed research- Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society (opens the source in a new tab)
- Class II recall: Testosterone Topical Cream 4% (opens the source in a new tab)
Reason: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.. Recalling firm: MPRX, Inc. dba Medical Park Pharmacy (TX). Status: Terminated.